Description
Retatrutide is a GLP1 class of peptide used in research to investigate obesity, type 2 diabetes, and related metabolic conditions. It simultaneously activates the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors i.e. a triple antagonist for GLP1

